|
Universal Vision Biotechnology Co., Ltd. is a biotechnology company focused on vision health services and products. Founded in 1994 by ophthalmologists Lin Pi-Rong and Ou Shu-Fang, the company operates the 'e-University' brand, which integrates ophthalmic equipment and authorized clinic partnerships with a direct retail eyewear channel. The business provides one-stop eye health solutions, combining medical technology applications with visual aesthetics. Since 2012, the company has expanded into mainland China, using the East China region as its base to offer comprehensive eye health services to consumers. Summarised from the company's own disclosures, fiscal year ended Oct 2026 |
Industry Medical Instruments & Supplies | Homepage uvb.com.tw |
| Sector Healthcare | IR page uvb.com.tw/investor | |
|
Tags
vision health, ophthalmic equipment, eyewear retail, biotechnology, eye care services, e-University
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | NT$ 9.998B |
| Market cap (USD) | $ 303.465M |
| P/E | 9.31 |
| PEG | 1.32 |
| P/BV | 2.38 |
| P/S | 2.27 |
| P/OCF | 5.98 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 27.3% |
| ROI | 25.9% |
| ROIC | 26.9% |
| Profit margin | 24.8% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | 7.0% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 6.3% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.204B | 4.228B | 4.082B | 3.494B | 2.632B | 2.053B | 1.419B | 1.195B | 1.082B | 1.073B | 1.014B | 988.437M | 916.311M | 767.285M | 831.532M | 691.599M |
| Net profit | 1.043B | 1.065B | 1.045B | 850.392M | 595.428M | 483.214M | 238.005M | 161.478M | 120.088M | 91.804M | 81.068M | 101.567M | 86.482M | -88.191M | 27.982M | -43.056M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 146 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/S | 2.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial information published on MOPS, newest first, subjects as filed in Chinese, guarantee and loan balance notices and routine equipment purchases included. The link opens the company's material information on MOPS. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Universal Vision Biotechnology Co., Ltd.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVES | 0.01% | 27,000 | $ 101.819K | Nov 16, 2026 |
| AVEE | 0.01% | 5,000 | $ 18.855K | Nov 16, 2026 |
| DEXC | 0.01% | 4,000 | $ 15.226K | Nov 12, 2026 |
| DFEV | 0.01% | 31,000 | $ 118.003K | Nov 12, 2026 |
| DFEM | 0.00% | 71,239 | $ 271.175K | Nov 12, 2026 |
| DFSE | 0.00% | 3,000 | $ 11.42K | Nov 12, 2026 |
| DFAE | 0.00% | 35,960 | $ 136.883K | Nov 12, 2026 |
| DFAX | 0.00% | 10,468 | $ 39.847K | Nov 12, 2026 |
| AVEM | 0.00% | 69,582 | $ 262.398K | Nov 16, 2026 |
| AVXC | 0.00% | 3,000 | $ 11.313K | Nov 16, 2026 |






